共 33 条
[1]
Takami A(2020)Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 Int J Hematol 395 1033-1034
[2]
Mehta P(2020)COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 80 607-613
[3]
McAuley DF(2020)SARS-CoV-2 infection associated hemophagocytic lymphohistiocytosis: an autopsy series with clinical and laboratory correlation medRxiv 395 497-506
[4]
Brown M(2020)Tocilizumab for hemophagocytic syndrome in a kidney transplant recipient with COVID-19 Ann Intern Med undefined undefined-undefined
[5]
Sanchez E(2020)Favorable anakinra responses in severe Covid-19 patients with secondary hemophagocytic lymphohistiocytosis Cell Host Microbe undefined undefined-undefined
[6]
Tattersall RS(2020)The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19 J Infect undefined undefined-undefined
[7]
Manson JJ(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet undefined undefined-undefined
[8]
Prilutskiy A(undefined)undefined undefined undefined undefined-undefined
[9]
Kritselis M(undefined)undefined undefined undefined undefined-undefined
[10]
Shevtsov A(undefined)undefined undefined undefined undefined-undefined